PSMAI cut-off value for mortality in men: 680.1 mm2/m2
Por um escritor misterioso
Descrição
The forest plots, Galbraith plot, sensitivity analysis, and subgroup
Increased prostate cancer specific mortality following radical prostatectomy in men presenting with voiding symptoms—A whole of population study - ScienceDirect
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies
Cemalettin AYDIN, Inonu University, Malatya, Faculty of Medicine
The TBI SBP Sweet Spot – Is 130-180 mmHg the New Normotension? – JournalFeed
Pre- and intratherapeutic predictors of overall survival in patients with advanced metastasized castration-resistant prostate cancer receiving Lu-177- PSMA-617 radioligand therapy, BMC Urology
ASCO GU 2022: Predicting the Outcome of mCPRC Patients after Lu-177 PSMA Therapy Using Semi-Quantitative and Visual Criteria in Baseline PSMA PET: An International Multicenter Retrospective Study
Kaplan-Meier survival curves of prostate cancer patients treated with
Head-to-head comparison of 68Ga-PSMA-11 PET/CT and 68Ga-PSMA-11 PET/MRI in the detection of biochemical recurrence of prostate cancer: summary of head-to-head comparison studies
ESMO 2021: PRINCE: Interim Analysis of the Phase Ib Study of 177Lu-PSMA-617 in Combination With Pembrolizumab for Metastatic Castration Resistant Prostate Cancer
Yusuf BAĞ, Medical Doctor, Inonu University, Malatya, Department of General Surgery
Early Prostate-Specific Antigen Changes and Clinical Outcome After 177Lu- PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer
Cancers, Free Full-Text
ESMO 2022: Lu-PSMA for Prostate Cancer Treatment
de
por adulto (o preço varia de acordo com o tamanho do grupo)
